Capricor Therapeutics
CAPR
#7981
Rank
โ‚ฌ0.24 B
Marketcap
5,44ย โ‚ฌ
Share price
-4.36%
Change (1 day)
-62.63%
Change (1 year)

Market capitalization of Capricor Therapeutics (CAPR)

Market cap: โ‚ฌ0.24 Billion

As of January 2026 Capricor Therapeutics has a market cap of โ‚ฌ0.24 Billion. This makes Capricor Therapeutics the world's 7981th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Capricor Therapeutics from 2002 to 2026

End of year Market Cap

Year Marketcap Change
2026โ‚ฌ0.24 B0.47%
2025โ‚ฌ0.24 B-59.77%
2024โ‚ฌ0.61 B351.67%
2023โ‚ฌ0.13 B49.96%
2022โ‚ฌ90.83 M45.38%
2021โ‚ฌ62.47 M9.57%
2020โ‚ฌ57.02 M854.65%
2019โ‚ฌ5.97 M-46.9%
2018โ‚ฌ11.24 M-66.77%
2017โ‚ฌ33.85 M-37.44%
2016โ‚ฌ54.11 M18.43%
2015โ‚ฌ45.69 M26.59%
2014โ‚ฌ36.09 M31.24%
2013โ‚ฌ27.5 M1634.92%
2012โ‚ฌ1.58 M-90.49%
2011โ‚ฌ16.66 M3.24%
2010โ‚ฌ16.14 M-29.44%
2009โ‚ฌ22.87 M55.79%
2008โ‚ฌ14.68 M-83.83%
2007โ‚ฌ90.77 M3866.32%
2006โ‚ฌ2.28 M-44.75%
2005โ‚ฌ4.14 M14.51%
2004โ‚ฌ3.61 M18.29%
2003โ‚ฌ3.05 M-69.75%
2002โ‚ฌ10.11 M

End of Day market cap according to different sources

On Jan 4th, 2026 the market cap of Capricor Therapeutics was reported to be:

โ‚ฌ1.25 Billion
by Nasdaq info icon info icon
โ‚ฌ0.24 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Cytokinetics
CYTK
โ‚ฌ6.45 B 2,495.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
โ‚ฌ23.37 M-90.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ427.27 B 171,708.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚ฌ11.99 B 4,721.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
โ‚ฌ1.53 B 517.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
โ‚ฌ7.78 M-96.87%๐Ÿ‡บ๐Ÿ‡ธ USA